rs147204644

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003285.3(TNR):​c.496A>G​(p.Thr166Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00468 in 1,613,638 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0040 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 22 hom. )

Consequence

TNR
NM_003285.3 missense

Scores

1
2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 3.79

Publications

9 publications found
Variant links:
Genes affected
TNR (HGNC:11953): (tenascin R) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The encoded protein is restricted to the central nervous system. The protein may play a role in neurite outgrowth, neural cell adhesion and modulation of sodium channel function. It is a constituent of perineuronal nets. [provided by RefSeq, Aug 2013]
TNR Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010126919).
BP6
Variant 1-175406219-T-C is Benign according to our data. Variant chr1-175406219-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 224864.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00404 (615/152298) while in subpopulation AMR AF = 0.00595 (91/15302). AF 95% confidence interval is 0.00533. There are 2 homozygotes in GnomAd4. There are 288 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNRNM_003285.3 linkc.496A>G p.Thr166Ala missense_variant Exon 3 of 23 ENST00000367674.7 NP_003276.3 Q92752-1A1L306
TNRNM_001328635.2 linkc.-400A>G 5_prime_UTR_variant Exon 3 of 23 NP_001315564.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNRENST00000367674.7 linkc.496A>G p.Thr166Ala missense_variant Exon 3 of 23 5 NM_003285.3 ENSP00000356646.1 Q92752-1

Frequencies

GnomAD3 genomes
AF:
0.00405
AC:
616
AN:
152180
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.00595
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00207
Gnomad MID
AF:
0.0287
Gnomad NFE
AF:
0.00581
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00428
AC:
1062
AN:
248350
AF XY:
0.00432
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.00550
Gnomad ASJ exome
AF:
0.00997
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00241
Gnomad NFE exome
AF:
0.00568
Gnomad OTH exome
AF:
0.00573
GnomAD4 exome
AF:
0.00475
AC:
6938
AN:
1461340
Hom.:
22
Cov.:
70
AF XY:
0.00470
AC XY:
3419
AN XY:
726960
show subpopulations
African (AFR)
AF:
0.000807
AC:
27
AN:
33474
American (AMR)
AF:
0.00523
AC:
234
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00977
AC:
255
AN:
26106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00147
AC:
127
AN:
86184
European-Finnish (FIN)
AF:
0.00227
AC:
121
AN:
53372
Middle Eastern (MID)
AF:
0.0104
AC:
60
AN:
5760
European-Non Finnish (NFE)
AF:
0.00521
AC:
5795
AN:
1111664
Other (OTH)
AF:
0.00528
AC:
319
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
390
781
1171
1562
1952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00404
AC:
615
AN:
152298
Hom.:
2
Cov.:
32
AF XY:
0.00387
AC XY:
288
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41570
American (AMR)
AF:
0.00595
AC:
91
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00720
AC:
25
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4824
European-Finnish (FIN)
AF:
0.00207
AC:
22
AN:
10616
Middle Eastern (MID)
AF:
0.0274
AC:
8
AN:
292
European-Non Finnish (NFE)
AF:
0.00581
AC:
395
AN:
68024
Other (OTH)
AF:
0.00711
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
33
67
100
134
167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00470
Hom.:
3
Bravo
AF:
0.00453
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00752
AC:
29
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00558
AC:
48
ExAC
AF:
0.00435
AC:
528
EpiCase
AF:
0.00627
EpiControl
AF:
0.00563

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TNR: BP4, BS2 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Parkinson disease Uncertain:1
Jan 01, 2016
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Inborn genetic diseases Benign:1
Dec 28, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
22
DANN
Benign
0.83
DEOGEN2
Benign
0.32
T;T
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.84
.;T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-0.62
T
MutationAssessor
Benign
1.3
L;L
PhyloP100
3.8
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.19
Sift
Benign
0.18
T;T
Sift4G
Benign
0.40
T;T
Polyphen
0.93
P;P
Vest4
0.27
MVP
0.50
MPC
0.21
ClinPred
0.022
T
GERP RS
5.1
PromoterAI
-0.0069
Neutral
Varity_R
0.19
gMVP
0.24
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147204644; hg19: chr1-175375355; API